Expression of the Infectious Bronchitis Virus Spike Protein by Recombinant Vaccinia Virus and Induction of Neutralizing Antibodies in Vaccinated Mice

References

1. Ball L. A., Young K. K., Anderson K., Collins P. L., Wertz G. W. 1986; Expression of the major glycoprotein G of human respiratory syncytial virus from recombinant vaccinia virus vectors. Proceedings of the National Academy of Sciences U.S.A.: 83246–250
   [Google Scholar]
2. Bennink J. R., Yewdell J. W., Smith G. L., Moller C., Moss B. 1984; Recombinant vaccinia virus primes and stimulates influenza virus haemagglutinin-specific cytotoxic T cells. Nature; London: 311578–579
   [Google Scholar]
3. Bennink J. R., Yewdell J. W., Smith G. L., Moss B. 1986; Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes. Journal of Virology 57:786–791
   [Google Scholar]
4. Binns M. M., Boursnell M. E. G., Cavanagh D., Pappin D. J. C., Brown T. D. K. 1985; Cloning and sequencing of the gene encoding the spike protein of the coronavirus IBV. Journal of General Virology 66:719–726
   [Google Scholar]
5. Cavanagh D. 1983a; Coronavirus IBV glycopolypeptides: size of their polypeptide moieties and nature of their oligosaccharides. Journal of General Virology 64:1187–1191
   [Google Scholar]
6. Cavanagh D. 1983b; Coronavirus IBV: further evidence that the surface projections are associated with two glycopolypeptides. Journal of General Virology 64:1787–1791
   [Google Scholar]
7. Cavanagh D., Darbyshire J. H., Davis P., Perters R. W. 1984; Induction of humoral neutralising and haemagglutination-inhibiting antibody by the spike protein of avian infectious bronchitis virus. Avian Pathology 13:573–583
   [Google Scholar]
8. Chomiak T. W., Luginbuhl R. E., Steele F. M. 1963; Serological differences between the Beaudette and Massachusetts strains of infectious bronchitis virus. Avian Diseases 7:325–331
   [Google Scholar]
9. Cremer K., Mackett M., Wohlenberg C., Notkins A. L., Moss B. 1985; Vaccinia virus recombinant expressing herpes simplex virus type I glycoprotein D prevents latent herpes in mice. Science 228:737–740
   [Google Scholar]
10. Darbyshire J. H., Rowell I. G., Cook J. K. A., Peters R. W. 1979; Taxonomic studies on strains of avian infectious bronchitis virus using neutralisation tests in tracheal organ cultures. Archives of Virology 61:227–238
    [Google Scholar]
11. Dretzen G., Bellard M., Sassone-Corsi P., Chambon P. 1981; A reliable method for the recovery of DNA fragments from agarose and acrylamide gels. Analytical Biochemistry 112:275–298
    [Google Scholar]
12. Elango N., Prince G. A., Murphy B. R., Ventakesan S., Chanock R. M., Moss B. 1986; Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein. Proceedings of the National Academy of Sciences U.S.A.: 831906–1910
    [Google Scholar]
13. Kieny M.-P., Lathe R., Drillien R., Spehner D., Skory S., Schmitt D., Wiktor T., Koprowski H., Lecocq J.-P. 1984; Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature; London: 312163–166
    [Google Scholar]
14. Mackett M., Smith G. L. 1986; Vaccinia virus expression vectors. Joural of General Virology 67:2067–2082
    [Google Scholar]
15. Mackett M., Smith G. L., Moss B. 1984; General method for production and selection of infectious vaccinia virus recombinants expressiong foreign genes. Journal of Virology 40:857–864
    [Google Scholar]
16. Mackett M., Yilma T., Rose J., Moss B. 1985; Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle. Science 227:433–435
    [Google Scholar]
17. Maniatis T., Fritsch E. F., Sambrook J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
18. Maxam A. M., Gilbert W. 1980; Sequencing end-labeled DNA with base-specific chemical cleavages. Methods in Enzymology 65:499–560
    [Google Scholar]
19. Mockett A. P. A. 1985; Envelope proteins of avian infectious bronchitis virus: purification and biological properties. Journal of Virological Methods 12:271–278
    [Google Scholar]
20. Mockett A. P. A., Cook J. K. A. 1986; The detection of specific IgM to infectious bronchitis virus in chicken serum using an ELISA. Avian Pathology 15:439–446
    [Google Scholar]
21. Mockett A. P. A., Cavanagh D., Brown T. D. K. 1984; Monoclonal antibodies to the SI spike and membrane proteins of avian infectious bronchitis coronavirus strain Massachusetts M41. Journal of General Virology 65:2281–2286
    [Google Scholar]
22. Moss B., Smith G. L., Gerin J. L., Purcell R. H. 1984; Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature; London: 31167–69
    [Google Scholar]
23. Paoletti E., Lipinskas B. R., Samsanoff C., Mercer S., Panicali D. 1984; Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D. Proceedings of the National Academy of Sciences U.S.A.: 81193–197
    [Google Scholar]
24. Reed L. J., Muench H. 1938; A simple method of estimating fifty percent endpoints. American Journal of Hygiene 27:493–497
    [Google Scholar]
25. Siddell S., Wege H., Ter Meulen V. 1983; The biology of coronaviruses. Journal of General Virology 64:761–776
    [Google Scholar]
26. Smith G, Mackett M., Moss B. 1983a; Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature; London: 302490–495
    [Google Scholar]
27. Smith G. L., Murphy B. R., Moss B. 1983b; Construction and characterizaton of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proceedings of the National Academy of Sciences U.S.A.: 807155–7159
    [Google Scholar]
28. Stern D. F., Sefton B. M. 1984; Coronavirus multiplication: the locations of the genes coding for the virion proteins on the avian infectious bronchitis virus genome. Journal of Virology 44:804–812
    [Google Scholar]
29. White J., Helenius A., Gething M.-J. 1982; Haemagglutinin of influenza virus expressed from a cloned gene promotes membrane fusion. Nature; London: 300658–659
    [Google Scholar]
30. Wiktor T. J., Macfarlan R. I., Reagan K. J., Dietzschold B., Curtis P. J., Wunner W. H., Kieny M.-P., Lathe R., Lecocq J.-P., Mackett M., Moss B., Koprowski H. 1984; Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proceedings of the National Academy of Sciences U.S.A.: 817194–7198
    [Google Scholar]
31. Yewdell J. W., Bennink J. R., Smith G. L., Moss B. 1985; Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proceedings of the National Academy of Sciences U.S.A.: 821785–1789
    [Google Scholar]